Cite

HARVARD Citation

    Buondonno, I. et al. (n.d.). Mitochondria-targeted doxorubicin: A new therapeutic strategy against drug-resistant osteosarcoma. European journal of cancer. pp. S71-. [Online]. 
  
Back to record